Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Gene | BRAF |
Variant | V600_W604delinsDG |
Impact List | indel |
Protein Effect | unknown |
Gene Variant Descriptions | BRAF V600_W604delinsDG results in the deletion of five amino acids in the protein kinase domain of the Braf protein from amino acids 488 to 493, combined with the insertion of an aspartic acid (D) and a glycine (G) at the same site (UniProt.org). V600_W604delinsDG results in increased pERK expression in patient samples (PMID: 39107839), but has not been fully biochemically characterized and therefore, its effect on Braf protein function is unknown. |
Associated Drug Resistance | |
Category Variants Paths |
BRAF mutant BRAF V600_W604delinsDG |
Transcript | NM_004333.6 |
gDNA | chr7:g.140753323_140753337delinsACCGTC |
cDNA | c.1798_1812delinsGACGGT |
Protein | p.V600_W604delinsDG |
Source Database | RefSeq |
Genome Build | GRCh38/hg38 |
Transcript | gDNA | cDNA | Protein | Source Database | Genome Build |
---|---|---|---|---|---|
NM_001354609.2 | chr7:g.140753323_140753337delinsACCGTC | c.1798_1812delinsGACGGT | p.V600_W604delinsDG | RefSeq | GRCh38/hg38 |
NM_004333.6 | chr7:g.140753323_140753337delinsACCGTC | c.1798_1812delinsGACGGT | p.V600_W604delinsDG | RefSeq | GRCh38/hg38 |
NM_001378474.1 | chr7:g.140753323_140753337delinsACCGTC | c.1798_1812delinsGACGGT | p.V600_W604delinsDG | RefSeq | GRCh38/hg38 |
NM_001378468.1 | chr7:g.140753323_140753337delinsACCGTC | c.1798_1812delinsGACGGT | p.V600_W604delinsDG | RefSeq | GRCh38/hg38 |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|---|---|---|---|---|---|---|
BRAF V600_W604delinsDG | glioblastoma | predicted - sensitive | Dabrafenib + Trametinib | Case Reports/Case Series | Actionable | In a clinical case study, a patient with epithelioid glioblastoma harboring BRAF V600_W604delinsDG responded to treatment with the combination of Tafinlar (dabrafenib) and Mekinist (trametinib) with clinical improvement lasting 3 months (PMID: 39107839). | 39107839 |